These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4063141)

  • 1. A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells.
    Hanson JA; Bean EA; Coombs AM; Moore JL
    Br J Cancer; 1985 Oct; 52(4):637-40. PubMed ID: 4063141
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8).
    Jones AC; Wilson PA; Steel GG
    Cancer Chemother Pharmacol; 1984; 13(2):109-13. PubMed ID: 6380788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the presence within tumours of clones that differ in sensitivity to cytostatic drugs.
    Håkansson L; Tropé C
    Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):35-40. PubMed ID: 4827349
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell clones with different sensitivity to cytostatic drugs in methylcholanthrene-induced mouse sarcomas.
    Håkansson L; Tropé C
    Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):41-7. PubMed ID: 4827350
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency.
    Warenius HM; Bleehen NM
    Br J Cancer; 1982 Jul; 46(1):45-50. PubMed ID: 7104196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.
    Hamilton TC; Young RC; Ozols RF
    Semin Oncol; 1984 Sep; 11(3):285-98. PubMed ID: 6385258
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro.
    Rupniak HT; Whelan RD; Hill BT
    Int J Cancer; 1983 Jul; 32(1):7-12. PubMed ID: 6683250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.
    Jones AC; Stratford IJ; Wilson PA; Peckham MJ
    Br J Cancer; 1982 Dec; 46(6):870-9. PubMed ID: 6891260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonogenic cell survival in cryopreserved human tumour cells.
    Selby PJ; Steel GG
    Br J Cancer; 1981 Feb; 43(2):143-8. PubMed ID: 7470378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melphalan-resistant lymphoblastoid cell lines established from patients with ovarian cancer treated with cross-linking agents.
    Maynard K; Musk P; Daunter B; Khoo SK; Parsons PG
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():333-41. PubMed ID: 2998314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to X-radiation and cytotoxic drugs of clonal subpopulations of different ploidy and metastatic potential isolated from RIF-1 mouse sarcoma.
    Reeve JG; Wright KA; Twentyman PR
    Br J Cancer; 1983 Jun; 47(6):841-8. PubMed ID: 6860550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays.
    Twentyman PR; Walls GA; Wright KA
    Br J Cancer; 1984 Nov; 50(5):625-31. PubMed ID: 6093839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive survival in vitro of recently explanted human tumour cells following exposure to vinblastine. A suggestion for improved clinical dose schedules.
    Wells J; Berry RJ; Laing AH
    Eur J Cancer (1965); 1976 Oct; 12(10):793-6. PubMed ID: 976287
    [No Abstract]   [Full Text] [Related]  

  • 15. MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.
    Yan C; Yang F; Zhou C; Chen X; Han X; Liu X; Ma H; Zheng W
    Int J Clin Exp Pathol; 2015; 8(3):2710-8. PubMed ID: 26045776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent action of radiation and cisplatin on the survival or recovery of human normal or tumour cells in vitro or in vivo.
    Basham C; Mills J; Douple EB; Roberts JJ
    Int J Radiat Biol; 1989 May; 55(5):807-20. PubMed ID: 2565941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
    Valeriote FA; Tolen SJ
    Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of gamma irradiation and vinblastine on transplanted leukemia cells in mice].
    Khenkin EV
    Vopr Onkol; 1974; 20(9):90-4. PubMed ID: 4428661
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect, with time, of melphalan on hematopoietic stem cells proliferating at different rates.
    Dunn CD
    J Natl Cancer Inst; 1974 Jan; 52(1):173-80. PubMed ID: 4810960
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of drug resistance in a murine mammary tumour.
    McMillan TJ; Stephens TC; Steel GG
    Br J Cancer; 1985 Dec; 52(6):823-32. PubMed ID: 4074637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.